Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL795P is a processed pseudogene derived from the 7SL RNA gene family. Pseudogenes are non-functional segments of DNA that resemble functional genes but generally lack the ability to encode functional RNA or protein products[5][6]. The 7SL RNA is the RNA component of the signal recognition particle (SRP), essential in targeting proteins to the endoplasmic reticulum in eukaryotes[1][3]; however, pseudogenes like RN7SL795P do not participate in this function as they are generally not transcribed or have lost coding potential due to truncation or mutation[5][6]. The majority of 7SL pseudogenes are evolutionary remnants and are not considered therapeutic targets, receptors, enzymes, or other conventional drug targets[6]. Pseudogenes can sometimes act as regulatory non-coding RNAs (e.g., as miRNA decoys in some well-studied oncogenic pseudogenes), but there is currently no evidence that RN7SL795P has such a function[2][4]. The presence of hundreds of 7SL-related pseudogenes in the human genome suggests retrotranspositional history, not direct biological activity or disease relevance[5]. Summary: - RN7SL795P is a non-coding RNA pseudogene, not a receptor, enzyme, or therapeutic target, and has no established biological, disease, or pharmacological role[6]. - There is nothing unique to RN7SL795P that would make it a target for drug development, biomarker studies, or safety assessment. - is_incorrect is true because the entry refers to a nonfunctional pseudogene and not a molecular target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SL795 pseudogene (RN7SL795P).